Background To date, no immunological data on COVID-19 heterologous vaccination schedules
in humans have been reported. We assessed the immunogenicity and reactogenicity of …

A monkeypox (MPX) outbreak has expanded worldwide since May 2022. We tested 147
clinical samples collected at different time points from 12 patients by real-time PCR. MPX DNA …

Health care workers (HCW) are a high-risk population to acquire SARS-CoV-2 infection
from patients or other fellow HCW. This study aims at estimating the seroprevalence against …

According to preliminary data, seroconversion after mRNA SARS‐CoV‐2 vaccination might
be unsatisfactory in Kidney Transplant Recipients (KTRs). However, it is unknown if …

Around 2·5 million deaths and more than 110 million COVID-19 cases have been reported
globally. Although it initially appeared that HIV infection was not a risk factor for COVID-19 or …

Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and the individual characteristics
influencing it, including the impact of pre-existing antibodies to human coronaviruses …

Background Two doses of mRNA vaccination have shown >94% efficacy at preventing
COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize …

Recently published studies have found an impaired immune response after SARS‐CoV‐2
vaccination in solid organ recipients. However, most of these studies have not assessed …

Rationale. Noncompliance with vaccination schedules undermines the potential benefits of
immunization. The purpose of this study was to evaluate whether a reminder of the next …

Background At the COVID-19 spring 2020 pandemic peak in Spain, prevalence of SARS-CoV-2
infection in a cohort of 578 randomly selected health care workers (HCWs) from Hospital …